Biotech Values

[DewDiligence]

Major FoB Collaborations

[TEVA and Samsung-BIIB have dropped Rituxan.]

 
                 Date   Targets  iHub References 
 Merck KGaA-RDY  6/12   oncology #msg-76359649 
 Daiichi-Coherus 5/12   *        #msg-75397629 
 Fujifilm-Kyowa  3/12   Humira   #msg-73800486 
 WPI-Bioton      2/12   insulin  #msg-74987123 
 WPI-AMGN       12/11   oncology #msg-70097496, #msg-70101928 
 BAX-MNTA       12/11   various  #msg-70212854, #msg-70258421 
 Samsung-BIIB   12/11   various  #msg-69629103, #msg-80622249 
 MRK-Hanwha      6/11   Enbrel   #msg-64164954, #msg-64193403  
 MYL-Biocon      6/09   various  #msg-39119393, #msg-72421544  
 TEVA-Lonza      1/09   various  #msg-34930012, #msg-80236315 
  
 *Enbrel and Rituxan in selected Asian countries.